Document is current
Any future updates will be listed below
-
Authors
Murphy, Anna
Howlett, David
Gowson, Aaron
Lewis, Harriet
-
Funding
Funding for this research was provided by:
Chiesi Limited
- License Information
-
More Information
Article History
Received: 17 June 2022
Accepted: 5 January 2023
First Online: 21 January 2023
Competing interests
: The authors declare no competing non-financial interests but the following competing financial interests: A.M. reports personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Insmed, and Orion, and grants from Chiesi, Novartis, and Orion. D.H. is director of and consultant at PharmaDelivery Solutions Ltd. A.G. and H.L. are employees of Chiesi Limited.
